Page last updated: 2024-09-03

(20s)-20-hydroxycholesterol and Neoplasms

(20s)-20-hydroxycholesterol has been researched along with Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Giannis, A; Heretsch, P; Tzagkaroulaki, L	1
Huang, TM; Huang, WJ; Tan, WF; Tang, WG; Wang, J; Yang, J; Zhang, Y	1

Reviews

1 review(s) available for (20s)-20-hydroxycholesterol and Neoplasms

Article	Year
Modulators of the hedgehog signaling pathway. Bioorganic & medicinal chemistry, 2010, Sep-15, Volume: 18, Issue:18 Topics: Antineoplastic Agents; Hedgehog Proteins; Humans; Neoplasms; Signal Transduction; Veratrum Alkaloids	2010

Other Studies

1 other study(ies) available for (20s)-20-hydroxycholesterol and Neoplasms

Article	Year
ABT-199 inhibits Hedgehog pathway by acting as a competitive inhibitor of oxysterol, rather as a BH3 mimetic. Acta pharmacologica Sinica, 2021, Volume: 42, Issue:6 Topics: Animals; Antineoplastic Agents; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Resistance, Neoplasm; Hedgehog Proteins; Humans; Hydroxycholesterols; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms; NIH 3T3 Cells; Protein Binding; Signal Transduction; Smoothened Receptor; Sulfonamides	2021

Article

Year

ABT-199 inhibits Hedgehog pathway by acting as a competitive inhibitor of oxysterol, rather as a BH3 mimetic.

Acta pharmacologica Sinica, 2021, Volume: 42, Issue:6

Topics: Animals; Antineoplastic Agents; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Resistance, Neoplasm; Hedgehog Proteins; Humans; Hydroxycholesterols; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms; NIH 3T3 Cells; Protein Binding; Signal Transduction; Smoothened Receptor; Sulfonamides

2021